Dowiedzieć się o najlepszych cenach i klinikach w EKO (zapłodnieniu in vitro) z wyborem płci w Hiszpanii w 2026 roku

Elective gender selection is strictly illegal in Spain under Law 14/2006. Clinics cannot perform sex selection for social reasons or family balancing. The law classifies non-medical gender selection as a very serious offense. This results in heavy penalties for healthcare facilities.

• Medical exception: Permitted only to prevent severe sex-linked hereditary genetic diseases.
• Authorized conditions: Includes Hemophilia A, Duchenne muscular dystrophy, and Fragile X syndrome.
• Testing method: Doctors use Preimplantation Genetic Testing (PGT) to identify male-linked risks.
• Clinic compliance: Facilities like Centro Médico Teknon strictly follow these national regulations.

Bookimed Expert Insight: While Spain ranks third globally for fertility requests, its regulations differ from countries like Cyprus. Spanish clinics prioritize embryo quality over sex preference. Even when tests reveal gender, medical viability dictates the transfer. Seek centers with JCI accreditation to ensure legal compliance.

Patient Consensus: Patients find clinic responses regarding sex selection can be vague. You should ask directly in writing if elective selection is permitted. Many warn that Europe has diverse laws and Spain is not for family balancing.

Medical exceptions for sex selection in Spain allow embryo screening exclusively to prevent the transmission of serious sex-linked genetic disorders. Spanish law prohibits elective gender selection, permitting the practice only when Preimplantation Genetic Testing (PGT) identifies specific hereditary risks like hemophilia or Duchenne muscular dystrophy.

• Genetic risk: Primary justification involves X-linked recessive disorders carried on the X chromosome.
• Condition types: Exceptions include Duchenne muscular dystrophy, Fragile X syndrome, and Hemophilia.
• Documentation: Clinics require formal proof of family history from a genetic specialist.
• Clinical process: Embryo biopsy during IVF identifies sex to avoid transferring affected embryos.

Bookimed Expert Insight: While Spanish clinics like Centro Médico Teknon must follow strict legal limits, their infrastructure is superior for diagnosis. Dr. Cayetana Barbed teaches reproductive biology, ensuring testing follows elite standards. Patients should know that ethics committees review every medical exception case individually. Spain ranks as our third most requested destination because this high-level screening is combined with clinical success.

Patient Consensus: Patients emphasize that Spanish clinics focus strictly on embryo viability and disease prevention. Documented medical history is essential as mental health or family balancing reasons are not accepted.

You cannot find out your embryo gender during routine IVF testing in Spain for personal choice or family balancing. Spanish Law 14/2006 strictly prohibits sex selection unless it prevents severe sex-linked genetic disorders like Haemophilia or Duchenne muscular dystrophy.

• Legal restriction: Spanish law classifies elective sex selection as a very serious legal offense.
• Medical exceptions: Disclosure is permitted only for preventing hereditary diseases tied to sex chromosomes.
• Genetic testing: PGT-A reveals chromosomal data, but clinics must withhold sex info by law.
• Specialized care: Centers like Centro Médico Teknon provide PGT-M for these specific medical cases.

Bookimed Expert Insight: While Spain ranks third globally for IVF requests, its regulations remain strictly therapeutic. Patients should note that even with high-end diagnostic tools, doctors like Cayetana Barbed must prioritize medical Necessity over preference. If family balancing is your primary goal, destinations like Mexico or Northern Cyprus offer legal avenues that Spanish clinics simply cannot provide due to local mandates.

Patient Consensus: Many feel Spain is more conservative than the U.S. regarding transparency. Most recommend explicitly asking clinics about their disclosure policies before starting PGT-A to avoid frustration later.

Families travel to the United States, Mexico, Northern Cyprus, Thailand, and the United Arab Emirates for elective gender selection. These hubs allow family balancing through IVF and Preimplantation Genetic Testing with 99.9% accuracy. Spain also serves international patients seeking advanced reproductive care under specific regulatory frameworks.

• Top destinations: The United States and Mexico lead for North American and European travelers.
• Legal status: Elective selection is legal in Northern Cyprus, the USA, and UAE (married couples).
• Procedure method: Clinics use IVF with PGT-A to identify biological sex before embryo transfer.
• Spanish centers: Facilities like Centro Médico Teknon in Barcelona offer comprehensive reproductive genetic screening.

Bookimed Expert Insight: Spain is a unique mid-range option for families who prioritize high-level clinical credentials over the lowest price. While Northern Cyprus offers lower costs, Spanish clinics like Centro Médico Teknon hold prestigious Joint Commission International accreditation and serve high-profile global patients. Our data shows patients choose Spain when they want a balance of European medical standards and experienced specialists like Dr. Cayetana Barbed.

Patient Consensus: Many families emphasize that this process requires a full IVF emotional and physical commitment. Patients frequently recommend confirming in writing that your chosen clinic permits gender disclosure for your specific case before traveling.

Gender selection does not biologically alter IVF success rates, as pregnancy odds depend on embryo quality rather than sex. However, the required preimplantation genetic testing (PGT) increases success per transfer by ensuring only chromosomally normal embryos are used, significantly reducing miscarriage risks.

• Genetic screening benefit: PGT identifies healthy embryos, raising implantation success regardless of gender.
• Embryo attrition risk: Prioritizing a specific sex may reduce the available pool of transferable embryos.
• Testing accuracy: Modern biopsy techniques allow for nearly 100% accurate sex identification and screening.
• Selection priority: Choosing lower-quality embryos based on gender can slightly lower overall pregnancy chances.

Bookimed Expert Insight: Success in Spain often depends more on lab precision than the selection itself. Clinics like Centro Médico Teknon utilize JCI-accredited labs where surgeons like Dr. Cayetana Barbed oversee complex PGT protocols. Data shows that while gender selection is popular for family balancing, the highest success rates occur when patients allow specialists to prioritize the highest-graded embryo from the tested pool.

Patient Consensus: Patients often reflect that while choosing a gender provides peace of mind, the emotional reality revolves around the number of healthy embryos available. Many suggest focusing on lab quality and transfer strategy rather than viewing gender as a factor that changes biological outcomes.

Gender selection is technically achieved through In Vitro Fertilization combined with Preimplantation Genetic Testing. Embryologists biopsy 2–5 cells from a day 5 blastocyst to analyze the 23rd chromosome pair. This method identifies biological sex with virtually 100% accuracy while screening for chromosomal abnormalities like Down syndrome.

• Embryo biopsy: Experts remove cells from the trophectoderm using a specialized laboratory laser.
• Genetic analysis: Technicians identify XX for female or XY for male embryos via PGT-A.
• ICSI technique: Surgeons often use Intracytoplasmic Sperm Injection to ensure high-quality embryo development.
• Cryopreservation step: Clinics freeze embryos while awaiting genetic results before the final transfer.

Bookimed Expert Insight: Spanish fertility centers like Centro Médico Teknon integrate PGT-M into selection protocols. This approach allows doctors to screen for specific monogenic disorders alongside sex identification. Dr. Cayetana Barbed’s coordination of advanced programs ensures that only the highest-viability embryos reach the biopsy stage.

Patient Consensus: Patients emphasize that success relies on embryo quality rather than just sex preference. Many prepare for the emotional reality that not every biopsied embryo is viable for transfer.

Qualifying for medical gender selection in Spain requires genetic evidence proving the need to prevent sex-linked hereditary diseases. Documentation must include official genetic counseling reports, a multi-generational family tree, and laboratory DNA results. All foreign records must have notarized Spanish translations to satisfy Spanish Law 14/2006 requirements.

• Genetic documentation: Diagnostic reports mapping specific sex-linked risks or monogenic disorders are mandatory.
• Laboratory results: Certified karyotype and DNA reports must confirm the parents' carrier status.
• Legal verification: Valid passports for both partners and an apostilled marriage certificate are required.
• Clinical consent: Signed informed consent forms specifically for PGT-M or structural rearrangement testing.

Bookimed Expert Insight: Spanish clinics like Centro Médico Teknon prioritize a complete medical dossier over simple applications. Our data shows successful approvals depend on a specialist's referral letter documenting medical necessity. We recommend using a genetic counselor to organize your family-history packet before your first consultation. This proactive approach significantly speeds up the clinic's internal medical board review process.

Patient Consensus: Patients emphasize that documentation must strictly focus on medical necessity rather than personal preference. Most administrative work involves proving genetic risk through detailed records of affected relatives and prior lab work.